The Schroeder Institute for Tobacco Research and Policy Studies at Legacy, Washington, DC 20036, USA.
Am J Public Health. 2013 Mar;103(3):562-7. doi: 10.2105/AJPH.2012.300890. Epub 2013 Jan 17.
We assessed public support for a potential Food and Drug Administration (FDA)-mandated reduction in cigarette nicotine content.
We used nationally representative data from a June 2010 cross-sectional survey of US adults (n = 2649) to obtain weighted point estimates and correlates of support for mandated nicotine reduction. We also assessed the potential role of political ideology in support of FDA regulation of nicotine.
Nearly 50% of the public supported mandated cigarette nicotine reduction, with another 28% having no strong opinion concerning this potential FDA regulation. Support for nicotine reduction was highest among Hispanics, African Americans, and those with less than a high school education. Among smokers, the odds of supporting FDA nicotine regulation were 2.77 times higher among smokers who intended to quit in the next 6 months than among those with no plans to quit.
Mandating nicotine reduction in cigarettes to nonaddictive levels may reduce youth initiation and facilitate adult cessation. The reasons behind nicotine regulation need to be communicated to the public to preempt tobacco industry efforts to impede such a regulation.
我们评估了公众对食品和药物管理局(FDA)强制降低香烟尼古丁含量的潜在支持。
我们使用了 2010 年 6 月对美国成年人(n=2649)进行的横断面调查的全国代表性数据,以获得加权点估计值和支持强制性尼古丁减少的相关因素。我们还评估了政治意识形态在支持 FDA 监管尼古丁方面的潜在作用。
近 50%的公众支持强制性降低香烟尼古丁含量,另有 28%的人对此种潜在的 FDA 监管没有强烈意见。在西班牙裔、非裔美国人和受教育程度低于高中的人群中,支持尼古丁减少的比例最高。在吸烟者中,与没有戒烟计划的吸烟者相比,计划在未来 6 个月内戒烟的吸烟者支持 FDA 尼古丁监管的几率高 2.77 倍。
将香烟中的尼古丁降低到非成瘾水平可能会减少青少年的吸烟率并促进成年人戒烟。需要向公众传达尼古丁监管的原因,以防止烟草业阻挠这一监管。